Bactericidal effects of amoxycillin/clavulanic acid against a Legionella pneumophila pneumonia in the weanling rat
- PMID: 2050589
- DOI: 10.1093/jac/27.1.127
Bactericidal effects of amoxycillin/clavulanic acid against a Legionella pneumophila pneumonia in the weanling rat
Abstract
Amoxycillin/clavulanic acid and clavulanic acid have been previously reported to demonstrate bactericidal activity in tissue culture studies against intracellular Legionella pneumophila. A rat model of legionellosis was therefore developed for the purpose of assessing the efficacy of these agents against L. pneumophila in vivo. Therapy by the subcutaneous route was started 12 h after infection when the majority of the bacteria observed in lavage fluid were residing in alveolar macrophages. Treatment with amoxycillin was ineffective in reducing the bacterial counts of L. pneumophila in lung homogenates whereas amoxycillin/clavulanic acid displayed bactericidal effects of the same order as the control antibiotic, erythromycin. Further in-vivo studies are planned to assess the clinical relevance of these findings.
Similar articles
-
Bactericidal effects of co-amoxiclav (amoxycillin clavulanic acid) against a Legionella pneumophila pneumonia in the immunocompromised weanling rat.J Antimicrob Chemother. 1992 Oct;30(4):525-34. doi: 10.1093/jac/30.4.525. J Antimicrob Chemother. 1992. PMID: 1490922
-
Activity of amoxycillin-clavulanic acid against Legionella pneumophila in vitro and in an experimental respiratory infection model.J Hosp Infect. 1992 Nov;22 Suppl A:61-7. doi: 10.1016/s0195-6701(05)80008-8. J Hosp Infect. 1992. PMID: 1362751
-
Combined therapy with co-amoxiclav and erythromycin against intracellular Legionella pneumophila in cell culture and in an experimental respiratory infection in neutropenic rats.J Antimicrob Chemother. 1995 Jun;35(6):889-93. doi: 10.1093/jac/35.6.889. J Antimicrob Chemother. 1995. PMID: 7559201 No abstract available.
-
Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992.J Chemother. 1993 Apr;5(2):67-93. doi: 10.1080/1120009x.1993.11739213. J Chemother. 1993. PMID: 8515298 Review.
-
Treatment of legionnaires' disease.Semin Respir Infect. 1998 Jun;13(2):140-6. Semin Respir Infect. 1998. PMID: 9643392 Review.
Cited by
-
Treatment of Legionnaires' disease.Drugs. 2005;65(5):605-14. doi: 10.2165/00003495-200565050-00003. Drugs. 2005. PMID: 15748096 Review.
-
Bactericidal effects of ticarcillin-clavulanic acid against Legionella pneumophila pneumonia in immunocompromised weanling rats.Antimicrob Agents Chemother. 1991 Jul;35(7):1423-9. doi: 10.1128/AAC.35.7.1423. Antimicrob Agents Chemother. 1991. PMID: 1929303 Free PMC article.
-
In vitro extracellular and intracellular activities of clavulanic acid and those of piperacillin and ceftriaxone alone and in combination with tazobactam against clinical isolates of Legionella species.Antimicrob Agents Chemother. 1994 Feb;38(2):200-4. doi: 10.1128/AAC.38.2.200. Antimicrob Agents Chemother. 1994. PMID: 8192443 Free PMC article.
-
Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella spp.Antimicrob Agents Chemother. 1994 Jan;38(1):144-6. doi: 10.1128/AAC.38.1.144. Antimicrob Agents Chemother. 1994. PMID: 8141570 Free PMC article.
-
Fatal Legionella pneumophila pneumonia: treatment failure despite early sequential oral-parenteral amoxicillin-clavulanic acid therapy.Infection. 1992 Mar-Apr;20(2):99-100. doi: 10.1007/BF01711076. Infection. 1992. PMID: 1582691
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical